The recent failure of a Merck HIV/AIDS vaccine candidate was a "disappointment," but "failure is the rule" in vaccine and drug development, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a Wall Street Journal opinion piece. ...